Asia Summit 2026

Investing in Discovery Science (Invite only)

-
REQUEST INVITE

Today's breakthroughs cancer prevention, detection, and treatment all began as discovery science. That kind of foundational work takes years to prove out, long before any commercial payoff. Across biomedical research, the earliest science is often the hardest to fund. This session explores innovative financing models that can support discovery research and its translation from the lab to the clinic. What structures can share the risk of early science? How can philanthropy, public funders, and private capital align behind the same promising research? And what will it take to invest in science that may take years to deliver?

    Moderator

    Image

    Yun Fu

    Associate Director, Innovative Finance, Milken Institute

    Speakers

    Image

    Wing Hong Shannon Cheung

    Chairman and CEO, Averest Capital
    Image

    Minami Maeda

    CEO, Rakuten Medical, Inc.
    Image

    Lisa Ooi

    Assistant Chief Executive, A*STAR Biomedical Research Council
    Image

    David Scott

    Director, Cancer Grand Challenges